118 related articles for article (PubMed ID: 15554773)
1. Treatment of posttraumatic stress disorder with phenytoin: an open-label pilot study.
Douglas Bremner J; Mletzko T; Welter S; Siddiq S; Reed L; Williams C; Heim CM; Nemeroff CB
J Clin Psychiatry; 2004 Nov; 65(11):1559-64. PubMed ID: 15554773
[TBL] [Abstract][Full Text] [Related]
2. Effects of phenytoin on memory, cognition and brain structure in post-traumatic stress disorder: a pilot study.
Bremner JD; Mletzko T; Welter S; Quinn S; Williams C; Brummer M; Siddiq S; Reed L; Heim CM; Nemeroff CB
J Psychopharmacol; 2005 Mar; 19(2):159-65. PubMed ID: 15728437
[TBL] [Abstract][Full Text] [Related]
3. Open-label trial of escitalopram in the treatment of posttraumatic stress disorder.
Robert S; Hamner MB; Ulmer HG; Lorberbaum JP; Durkalski VL
J Clin Psychiatry; 2006 Oct; 67(10):1522-6. PubMed ID: 17107242
[TBL] [Abstract][Full Text] [Related]
4. Divalproex in posttraumatic stress disorder: an open-label clinical trial.
Clark RD; Cañive JM; Calais LA; Qualls CR; Tuason VB
J Trauma Stress; 1999 Apr; 12(2):395-401. PubMed ID: 10378177
[TBL] [Abstract][Full Text] [Related]
5. Levetiracetam for treatment-refractory posttraumatic stress disorder.
Kinrys G; Wygant LE; Pardo TB; Melo M
J Clin Psychiatry; 2006 Feb; 67(2):211-4. PubMed ID: 16566615
[TBL] [Abstract][Full Text] [Related]
6. Nefazodone in patients with treatment-refractory posttraumatic stress disorder.
Zisook S; Chentsova-Dutton YE; Smith-Vaniz A; Kline NA; Ellenor GL; Kodsi AB; Gillin JC
J Clin Psychiatry; 2000 Mar; 61(3):203-8. PubMed ID: 10817106
[TBL] [Abstract][Full Text] [Related]
7. Baclofen treatment for chronic posttraumatic stress disorder.
Drake RG; Davis LL; Cates ME; Jewell ME; Ambrose SM; Lowe JS
Ann Pharmacother; 2003 Sep; 37(9):1177-81. PubMed ID: 12921495
[TBL] [Abstract][Full Text] [Related]
8. A preliminary study of risperidone in the treatment of posttraumatic stress disorder related to childhood abuse in women.
Reich DB; Winternitz S; Hennen J; Watts T; Stanculescu C
J Clin Psychiatry; 2004 Dec; 65(12):1601-6. PubMed ID: 15641864
[TBL] [Abstract][Full Text] [Related]
9. Prospective study to evaluate the efficacy of aripiprazole as a monotherapy in patients with severe chronic posttraumatic stress disorder: an open trial.
Villarreal G; Calais LA; Cañive JM; Lundy SL; Pickard J; Toney G
Psychopharmacol Bull; 2007; 40(2):6-18. PubMed ID: 17514183
[TBL] [Abstract][Full Text] [Related]
10. Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline.
Brady KT; Clary CM
Compr Psychiatry; 2003; 44(5):360-9. PubMed ID: 14505296
[TBL] [Abstract][Full Text] [Related]
11. An open-label study of mirtazapine as treatment for combat-related PTSD.
Alderman CP; Condon JT; Gilbert AL
Ann Pharmacother; 2009 Jul; 43(7):1220-6. PubMed ID: 19584388
[TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind, placebo-controlled trial to assess the efficacy of topiramate in the treatment of post-traumatic stress disorder.
Mello MF; Yeh MS; Barbosa Neto J; Braga LL; Fiks JP; Mendes DD; Moriyama TS; Valente NL; Costa MC; Mattos P; Bressan RA; Andreoli SB; Mari JJ
BMC Psychiatry; 2009 May; 9():28. PubMed ID: 19480669
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, placebo-controlled trial of augmentation topiramate for chronic combat-related posttraumatic stress disorder.
Lindley SE; Carlson EB; Hill K
J Clin Psychopharmacol; 2007 Dec; 27(6):677-81. PubMed ID: 18004136
[TBL] [Abstract][Full Text] [Related]
14. Open trial of nefazodone for combat veterans with posttraumatic stress disorder.
Garfield DA; Fichtner CG; Leveroni C; Mahableshwarkar A
J Trauma Stress; 2001 Jul; 14(3):453-60. PubMed ID: 11534877
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Quetiapine Monotherapy in Posttraumatic Stress Disorder: A Randomized, Placebo-Controlled Trial.
Villarreal G; Hamner MB; Cañive JM; Robert S; Calais LA; Durklaski V; Zhai Y; Qualls C
Am J Psychiatry; 2016 Dec; 173(12):1205-1212. PubMed ID: 27418378
[TBL] [Abstract][Full Text] [Related]
16. Open-label topiramate as primary or adjunctive therapy in chronic civilian posttraumatic stress disorder: a preliminary report.
Berlant J; van Kammen DP
J Clin Psychiatry; 2002 Jan; 63(1):15-20. PubMed ID: 11838620
[TBL] [Abstract][Full Text] [Related]
17. An open-label assessment of aripiprazole in the treatment of PTSD.
Robert S; Hamner MB; Durkalski VL; Brown MW; Ulmer HG
Psychopharmacol Bull; 2009; 42(1):69-80. PubMed ID: 19204652
[TBL] [Abstract][Full Text] [Related]
18. Prospective open-label study of add-on and monotherapy topiramate in civilians with chronic nonhallucinatory posttraumatic stress disorder.
Berlant JL
BMC Psychiatry; 2004 Aug; 4():24. PubMed ID: 15315714
[TBL] [Abstract][Full Text] [Related]
19. Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder.
McRae AL; Brady KT; Mellman TA; Sonne SC; Killeen TK; Timmerman MA; Bayles-Dazet W
Depress Anxiety; 2004; 19(3):190-6. PubMed ID: 15129422
[TBL] [Abstract][Full Text] [Related]
20. The alpha1-adrenergic antagonist prazosin improves sleep and nightmares in civilian trauma posttraumatic stress disorder.
Taylor F; Raskind MA
J Clin Psychopharmacol; 2002 Feb; 22(1):82-5. PubMed ID: 11799347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
